Neoclone - We excel in the manufacture of monoclonal antibodies
Search

Can't Find It? Try Our Site Map
Product Catalog Custom Services Company Support
 

COMPANY
NeoClone News
NeoClone and Scarab Genomics reach licensing deal to market Shiga Toxin antibodies
NeoClone and Scarab Genomics partner to develop and market Shiga Toxin antibodies.
6/07: NeoClone receives $750K federal contract for ovarian cancer detection

11/05: NeoClone featured in Wisconsin Capital Times Article on Debt Funding
9/05: NeoClone and Pierce Biotechnology agree to co-develop novel immunoaffinity products.
9/05: NeoClone presents at BIO Mid-America Venture Forum
NeoClone CEO Deven McGlenn presented at the BIO Mid-America Venture Forum in Minneapolis on September 21st-23rd, 2005.
3/05: NeoClone Presents at Proteomics Interest Group Meeting of the NCI EDRN Steering Committee
2/05: NeoClone Participates in Jetro BioMission to Chiba Prefecture
1/05: NeoClone certified as New Business Venture by State of Wisconsin Department of Commerce
11/04: NeoClone Biotechnology awarded a Phase I SBIR Contract from the National Cancer Institute to develop antibody microarrays
8/04: Abstract of article appearing in August issue of Genetic Engineering News
6/04: Read about NeoClone and Wisconsin biotechnology as featured in Milwaukee Journal Sentinel
6/04: NeoClone featured in Modern Drug Discovery article on Wisconsin biotech activity
6/04: NeoClone Licensed Protein Purification System from WARF
3/04: NeoClone Secures Wisconsin Development Funding
12/03: NeoClone Hires Dr. Michael Zwick to Fill VP of Business Development

© Copyright 2002-2003 Neoclone - All Rights Reserved.